Latest Articles

Publication Date
XPR1: Emerging Prognostic Marker in Endometrial Cancer - BIOENGINEER.ORG

XPR1: Emerging Prognostic Marker in Endometrial Cancer BIOENGINEER.ORG

Published: Sept. 2, 2025, 9:51 a.m.
Triptorelin associated adverse events evaluated using FAERS pharmacovigilance data.

Triptorelin, a gonadotropin-releasing hormone(GnRH) agonist, is approved by the US Food and Drug Administration(FDA) for treating advanced prostate cancer, endometriosis, and central precocious puberty(CPP) in children aged ≥ 2 years. …

Published: Sept. 1, 2025, midnight
Application of ultrasound in combination with other methods in gynecological disease: artificial intelligence, surgery, and drugs.

Gynecological diseases (GyD) are related to reproductive tissue disorders such as the cervix, vagina, fallopian tubes, and ovaries, which can affect fertility. Among these diseases, we can mention endometriosis, ovarian …

Published: Sept. 1, 2025, midnight
Uterine Cancer: Raising Awareness for Overlooked Risk - Mirage News

Uterine Cancer: Raising Awareness for Overlooked Risk Mirage News

Published: Aug. 31, 2025, 11:13 p.m.
Adenomyosis-associated uterine rupture and pulmonary endometriosis mimicking advanced-stage uterine malignancy in an adolescent female: A case report.

Uterine adenomyosis and pulmonary endometriosis are exceptionally rare in adolescents and can pose significant diagnostic challenges due to their nonspecific clinical presentation and imaging features, which may mimic malignancy. Here, …

Published: Aug. 30, 2025, midnight
Lactate-Induced M2 Macrophages Boost Endometrial Cancer Progression - BIOENGINEER.ORG

Lactate-Induced M2 Macrophages Boost Endometrial Cancer Progression BIOENGINEER.ORG

Published: Aug. 29, 2025, 10:40 p.m.
Research progress of probiotics intervention on reconstruction of intestinal flora and improvement of quality of life in patients after endometrial cancer surgery - Frontiers

Research progress of probiotics intervention on reconstruction of intestinal flora and improvement of quality of life in patients after endometrial cancer surgery Frontiers

Published: Aug. 29, 2025, 7:07 p.m.
Polymerase Mutations Shape Distinct Cancer Risks - Conexiant

Polymerase Mutations Shape Distinct Cancer Risks Conexiant

Published: Aug. 28, 2025, 4:15 p.m.
Survival Varies by Age With HT in Endometrial Cancer - Medscape

Survival Varies by Age With HT in Endometrial Cancer Medscape

Published: Aug. 28, 2025, 3:05 p.m.
Genmab shares rise 1.21% premarket after FDA grants Breakthrough Therapy Designation to Rina-S for endometrial cancer treatment. - AInvest

Genmab shares rise 1.21% premarket after FDA grants Breakthrough Therapy Designation to Rina-S for endometrial cancer treatment. AInvest

Published: Aug. 28, 2025, 8:24 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!